Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended 30th September, 2026.

To Date: 13.10.2026 BSE Limited P. J. Towers, Dalal Street, Mumbai – 400001. Dear Sir / Madam, Unit: Oxygenta Pharmaceutical Ltd (Scrip Code: 524636) Sub: Compliance as per Regulation 74(5) of the SEBI [Depositories and Participants] Regulations, 2018 for the Quarter ended 30th September, 2026. This is to certify that details of securities dematerialized during the quarter ended 30th September, 2026 as required under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations 2018, have been furnished to all the stock exchanges where the shares of the Company are listed. The letter dated 05.10.2026 received from M/s. Venture Capital and Corporate Investments Private Limited (RTA) confirming the same is enclosed for your reference. This is for the information and records of the Exchange, please. Thanking you. Yours faithfully, For Oxygenta Pharmaceutical Limited Kumkum Bajaj Company Secretary & Compliance Officer M no.: ACS76548 Encl: To Date: 05-10-2026 THE COMPANY SECRETARY OXYGENTA PHARMACEUTICAL LIMITED LEVEL-1 PLOT NO B1 AND B2 IDA GANDHI NAGAR, BALANAGAR TOWNSHIP RANGAREDDY, HYDERABAD TELANGANA - 500037 Dear Sir/Madam, Sub: Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 30.09.2026 Ref: Security Code – 524636 ISIN: INE102E01018 We hereby certify that the securities received for dematerialisation have been mutilated and cancelled after due verification and the name of the depositories (National Securities Depository Limited (NSDL) and Central Depository Services (India) Limited (CDSL) has been updated in the records of company as the registered owner within 15 days of receipt of valid DRF & Share certificate of said company and the details of securities are furnished to the stock exchange(s). We request you to take this information on record and to inform Depositories(s) and Stock Exchange(s) wherever your securities are listed accordingly. Thanking you, Yours faithfully, for Venture Capital and Corporate Investments Private Limited. Authorised Signatory. Note : You are requested to inform Depositories(s) and Stock Exchange(s) wherever your security is listed accordingly.